JOHN C MARTIN Insider Trading $GILD GILEAD SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN C MARTIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN C MARTIN. JOHN C MARTIN is Chairman and CEO in GILEAD SCIENCES INC ($GILD) and Director in GILEAD SCIENCES INC ($GILD) and Executive Chairman in GILEAD SCIENCES INC ($GILD) and President and CEO in GILEAD SCIENCES INC ($GILD) and Director in Sarepta Therapeutics, Inc. ($SRPT) and Director in Kronos Bio, Inc. ($KRON).
JOHN C MARTIN in GILEAD SCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN C MARTIN: Director, Executive Chairman, Chairman and CEO, President and CEO
Holdings: 2,885,507 shares
Current Value: $211,017,127
Latest Transaction: Feb 08 2019
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN C MARTIN in GILEAD SCIENCES INC
Sentiment: All, GILD, KRON, SRPT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.11 | 7,657 | 284,151 | 683,319 | 691 K to 683.3 K (-1.11 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.50 | 29,100 | 1,091,250 | 690,976 | 720.1 K to 691 K (-4.04 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.51 | 100 | 3,751 | 720,076 | 720.2 K to 720.1 K (-0.01 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.52 | 1,638 | 61,458 | 720,176 | 721.8 K to 720.2 K (-0.23 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.53 | 200 | 7,506 | 721,814 | 722 K to 721.8 K (-0.03 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.58 | 10,000 | 375,800 | 722,014 | 732 K to 722 K (-1.37 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.60 | 5,000 | 188,000 | 732,014 | 737 K to 732 K (-0.68 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.63 | 10,000 | 376,300 | 737,014 | 747 K to 737 K (-1.34 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.76 | 5,000 | 188,800 | 747,014 | 752 K to 747 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.80 | 5,000 | 189,000 | 752,014 | 757 K to 752 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.86 | 5,000 | 189,300 | 757,014 | 762 K to 757 K (-0.66 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.89 | 5,000 | 189,450 | 762,014 | 767 K to 762 K (-0.65 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.90 | 5,000 | 189,500 | 767,014 | 772 K to 767 K (-0.65 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.92 | 10,000 | 379,200 | 772,014 | 782 K to 772 K (-1.28 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 37.94 | 5,000 | 189,700 | 782,014 | 787 K to 782 K (-0.64 %) |
| Nov 08 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 4.09 | 120,000 | 491,256 | 787,014 | 667 K to 787 K (+17.99 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 15,000 | 122,813 | 213,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 2,000 | 16,375 | 228,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 13,000 | 106,438 | 230,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 15,000 | 122,813 | 243,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 5,000 | 40,938 | 258,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 8.19 | 10,000 | 81,875 | 263,360 | |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 63.77 | 15,000 | 956,550 | 332,790 | 347.8 K to 332.8 K (-4.31 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 15,000 | 122,813 | 347,790 | 332.8 K to 347.8 K (+4.51 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 63.70 | 2,000 | 127,400 | 332,790 | 334.8 K to 332.8 K (-0.60 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 2,000 | 16,375 | 334,790 | 332.8 K to 334.8 K (+0.60 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 63.50 | 13,000 | 825,500 | 332,790 | 345.8 K to 332.8 K (-3.76 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 13,000 | 106,438 | 345,790 | 332.8 K to 345.8 K (+3.91 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 63.55 | 15,000 | 953,250 | 332,790 | 347.8 K to 332.8 K (-4.31 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 15,000 | 122,813 | 347,790 | 332.8 K to 347.8 K (+4.51 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.75 | 5,000 | 313,750 | 332,790 | 337.8 K to 332.8 K (-1.48 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 5,000 | 40,938 | 337,790 | 332.8 K to 337.8 K (+1.50 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.86 | 10,000 | 628,600 | 332,790 | 342.8 K to 332.8 K (-2.92 %) |
| Aug 05 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 8.19 | 10,000 | 81,875 | 342,790 | 332.8 K to 342.8 K (+3.00 %) |
| May 07 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 1,500 | 0 | 332,790 | 334.3 K to 332.8 K (-0.45 %) |
| May 07 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Gift | G | 0.00 | 1,500 | 0 | 334,290 | 335.8 K to 334.3 K (-0.45 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 3,500 | 19,688 | 0 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 10,000 | 56,250 | 3,500 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 6,500 | 36,563 | 13,500 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 5,000 | 28,125 | 20,000 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 5,000 | 28,125 | 25,000 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 10,000 | 56,250 | 30,000 | |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.80 | 3,500 | 212,800 | 335,790 | 339.3 K to 335.8 K (-1.03 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 3,500 | 19,688 | 339,290 | 335.8 K to 339.3 K (+1.04 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.60 | 10,000 | 606,000 | 335,790 | 345.8 K to 335.8 K (-2.89 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 10,000 | 56,250 | 345,790 | 335.8 K to 345.8 K (+2.98 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.46 | 6,500 | 392,990 | 335,790 | 342.3 K to 335.8 K (-1.90 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 6,500 | 36,563 | 342,290 | 335.8 K to 342.3 K (+1.94 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.70 | 5,000 | 303,500 | 335,790 | 340.8 K to 335.8 K (-1.47 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 5,000 | 28,125 | 340,790 | 335.8 K to 340.8 K (+1.49 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.90 | 5,000 | 304,500 | 335,790 | 340.8 K to 335.8 K (-1.47 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 5,000 | 28,125 | 335,790 | 330.8 K to 335.8 K (+1.51 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 60.95 | 10,000 | 609,500 | 335,790 | 345.8 K to 335.8 K (-2.89 %) |
| May 04 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 10,000 | 56,250 | 345,790 | 335.8 K to 345.8 K (+2.98 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 5.63 | 50,000 | 281,250 | 40,000 | |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 14.59 | 10,000 | 145,938 | 24,820 | |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.40 | 10,000 | 564,000 | 335,790 | 345.8 K to 335.8 K (-2.89 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.60 | 10,000 | 566,000 | 345,790 | 355.8 K to 345.8 K (-2.81 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.55 | 10,000 | 565,500 | 355,790 | 365.8 K to 355.8 K (-2.73 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.51 | 10,000 | 565,100 | 365,790 | 375.8 K to 365.8 K (-2.66 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 56.49 | 10,000 | 564,900 | 375,790 | 385.8 K to 375.8 K (-2.59 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 5.63 | 50,000 | 281,250 | 385,790 | 335.8 K to 385.8 K (+14.89 %) |
| Feb 09 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 6.53 | 10,000 | 65,313 | 335,790 | 325.8 K to 335.8 K (+3.07 %) |
| Jan 30 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | A | 61.06 | 423,363 | 25,850,545 | 423,363 | |
| Jan 30 2004 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | A | 61.06 | 1,637 | 99,955 | 1,637 |